Royal DSM, Sinochem Group deal

Sinochem will acquire a 50% stake in Royal DSM's DSM Anti-Infectives group for €210 million ($276.1 million), forming a 50/50 JV with headquarters in Hong Kong. The group markets beta lactam antibioti...